Drew Moghanaki: More fuel to the fire on debates about “more immunotherapy” after surgery
Drew Moghanaki, Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology at UCLA, shared a post on X about a recent paper by William Phillips et al. published in Journal of Thoracic Oncology:
“More fuel to the fire on debates about ‘more immunotherapy’ after surgery.”
Authors: William Phillips, Ross Camidge, Paul Wheatley-Price
Dr. Drew Moghanaki is a Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology, UCLA. He holds the Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at the same university.
He specializes in treating lung cancer and other thoracic malignancies, focusing on advanced radiation therapy techniques like stereotactic body radiation therapy (SBRT), magnetic resonance-guided radiation therapy (MRgRT), and intensity-modulated radiation therapy (IMRT).
More posts featuring Drew Moghanaki.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023